Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke Multicenter Cohort Study

被引:24
作者
Kurmann, Rebekka [1 ]
Engelter, Stefan T. [2 ,3 ]
Michel, Patrik [4 ,5 ]
Luft, Andreas R. [6 ,7 ]
Wegener, Susanne [6 ]
Branscheidt, Meret [6 ]
Eskioglou, Elissavet [4 ,5 ]
Sirimarco, Gaia [4 ,5 ]
Lyrer, Philippe A. [2 ]
Gensicke, Henrik [2 ,3 ]
Horvath, Thomas [1 ]
Fischer, Urs [1 ]
Arnold, Marcel [1 ]
Sarikaya, Hakan [1 ]
机构
[1] Univ Hosp Berne, Dept Neurol, Freiburgstr 10, CH-3010 Bern, Switzerland
[2] Univ Hosp Basel, Stroke Ctr & Neurol, Basel, Switzerland
[3] Univ Hosp Basel, Felix Platter Hosp, Univ Ctr Med Aging & Rehabil, Neurorehabil Unit, Basel, Switzerland
[4] CHU Vaudois, Dept Neurol, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
[6] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland
[7] Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland
基金
瑞士国家科学基金会;
关键词
atrial fibrillation; hypertension; middle cerebral artery; prognosis; smokers; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; CEREBRAL-ISCHEMIA; CIGARETTE-SMOKING; CARDIOEMBOLIC STROKE; SAFE IMPLEMENTATION; SEX-DIFFERENCES; HUMAN BRAIN; RISK-FACTOR;
D O I
10.1161/STROKEAHA.117.017976
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The impact of smoking on prognosis after stroke is controversial. We aimed to assess the relationship between smoking status and stroke outcome after intravenous thrombolysis in a large cohort study by adjusting for potential confounders and incorporating recanalization rates. Methods-In a prospective observational multicenter study, we analyzed baseline and outcome data of consecutive patients with acute ischemic stroke treated with intravenous thrombolysis. Using uni- and multivariable modeling, we assessed whether smoking was associated with favorable outcome (modified Rankin Scale score of 0-1) and mortality. In addition, we also measured the occurrence of symptomatic intracranial hemorrhage and recanalization of middle cerebral artery. Patients reporting active cigarette use were classified as smokers. Results-Of 1865 patients, 19.8% were smokers (n=369). They were younger (mean 63.5 versus 71.3 years), less often women (56% versus 72.1%), and suffered less often from hypertension (61.3% versus 70.1%) and atrial fibrillation (22.7% versus 35.6%) when compared with nonsmokers. Favorable outcome and 3-month mortality were in favor of smokers in unadjusted analyses (45.8% versus 39.5% and 9.3% versus 15.8%, respectively), whereas symptomatic intracranial hemorrhage was comparable in both cohorts. Smoking was not associated with clinical outcome and mortality after adjusting for confounders (odds ratio, 1.20; 95% confidence interval, 0.91-1.61; P=0.197 and odds ratio, 1.08; 95% confidence interval, 0.68-1.71; P=0.755, respectively). However, smoking still independently predicted recanalization of middle cerebral artery in multivariable analyses (odds ratio, 2.68; 95% confidence interval, 1.11-6.43; P=0.028). Conclusions-Our study suggests that good outcome in smokers is mainly related to differences in baseline characteristics and not to biological effects of smoking. The higher recanalization rates in smokers, however, call for further studies.
引用
收藏
页码:1170 / +
页数:9
相关论文
共 48 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Association of Admission Blood Glucose and Outcome in Patients Treated With Intravenous Thrombolysis
    Ahmed, Niaz
    Davalos, Antoni
    Eriksson, Niclas
    Ford, Gary A.
    Glahn, Joerg
    Hennerici, Michael
    Mikulik, Robert
    Kaste, Markku
    Lees, Kennedy R.
    Lindsberg, Perttu J.
    Toni, Danilo
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (09) : 1123 - 1130
  • [3] Arboix A, 2011, EXPERT REV CARDIOVAS, V9, P367, DOI [10.1586/ERC.10.192, 10.1586/erc.10.192]
  • [4] Does smoking influence outcome after intravenous thrombolysis for acute ischaemic stroke?
    Aries, M. J. H.
    Uyttenboogaart, M.
    Koch, M. W.
    Langedijk, M.
    Vroomen, P. C.
    Luijckx, G. J.
    De Keyser, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (07) : 819 - 822
  • [5] SIGNIFICANCE OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - EXPERIENCE GLEANED FROM THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL
    BARBASH, GI
    WHITE, HD
    MODAN, M
    DIAZ, R
    HAMPTON, JR
    HEIKKILA, J
    KRISTINSSON, A
    MOULOPOULOS, S
    ERNESTO
    PAOLASSO
    VANDERWERF, T
    PEHRSSON, K
    SANDOE, E
    SIMES, J
    WILCOX, RG
    VERSTRAETE, M
    VONDERLIPPE, G
    VANDEWERF, F
    [J]. CIRCULATION, 1993, 87 (01) : 53 - 58
  • [6] MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE
    BROTT, T
    ADAMS, HP
    OLINGER, CP
    MARLER, JR
    BARSAN, WG
    BILLER, J
    SPILKER, J
    HOLLERAN, R
    EBERLE, R
    HERTZBERG, V
    RORICK, M
    MOOMAW, CJ
    WALKER, M
    [J]. STROKE, 1989, 20 (07) : 864 - 870
  • [7] Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
    Brott, T
    Broderick, J
    Kothari, R
    ODonoghue, M
    Barsan, W
    Tomsick, T
    Spilker, J
    Miller, R
    Sauerbeck, L
    Farrell, J
    Kelly, J
    Perkins, T
    Miller, R
    McDonald, T
    Rorick, M
    Hickey, C
    Armitage, J
    Perry, C
    Thalinger, K
    Rhude, R
    Schill, J
    Becker, PS
    Heath, RS
    Adams, D
    Reed, R
    Klei, M
    Hughes, A
    Anthony, J
    Baudendistel, D
    Zadicoff, C
    Rymer, M
    Bettinger, I
    Laubinger, P
    Schmerler, M
    Meiros, G
    Lyden, P
    Dunford, J
    Zivin, J
    Rapp, K
    Babcock, T
    Daum, P
    Persona, D
    Brody, M
    Jackson, C
    Lewis, S
    Liss, J
    Mahdavi, Z
    Rothrock, J
    Tom, T
    Zweifler, R
    [J]. STROKE, 1997, 28 (11) : 2109 - 2118
  • [8] Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke
    Brown, DL
    Johnston, KC
    Wagner, DP
    Haley, EC
    [J]. STROKE, 2004, 35 (01) : 147 - 150
  • [9] Gender issues in acute stroke thrombolysis
    De Silva, D. A.
    Ebinger, M.
    Davis, S. M.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (04) : 501 - 504
  • [10] Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe - Data from a multicenter multinational hospital-based registry
    Di Carlo, A
    Lamassa, M
    Baldereschi, M
    Pracucci, G
    Basile, AM
    Wolfe, CDA
    Giroud, M
    Rudd, A
    Ghetti, A
    Inzitari, D
    [J]. STROKE, 2003, 34 (05) : 1114 - 1119